k.bettencourt
TL2 Member · Grenoble, FR
Practical questions, practical answers. Not interested in speculation without a source.
Joined 3 June 2025 · last posted 1d
86 posts, newest first. Showing up to 150.
-
Conditions that change the calculus rather than forbidding it Replied, post #33 · Safety › Contraindications · 27 Jul 2026 · 13 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Seven-day rolling means and why weekly readings mislead Replied, post #117 · Outcomes › Progress reports · 26 Jul 2026 · 13 likes Worth separating two things that post #113 runs together. Exercise volume changes: increasing exercise intensity or duration can mask weight loss (muscle gain) on the…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #117 · Evidence › Preprints · 26 Jul 2026 · 14 likes post #116 answers the question as asked. The question underneath it is different. What changes between preprint and publication: authors respond to reviewer comments,…
-
What a certificate commits its issuer to Replied, post #68 · Analytics › COA interpretation · 20 Jul 2026 · 19 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #73 · Nutrition & Training › Protein & intake · 17 Jul 2026 · 6 likes post #72 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #69 · Sourcing › Independent verification · 6 Jul 2026 · 14 likes post #68 answers the question as asked. The question underneath it is different. Janoshik Analytical: chromatographic purity and mass-spectrometric identity on…
-
Sleep apnoea improving and the equipment implications Replied, post #11 · Wellbeing › Sleep · 3 Jul 2026 · 31 likes Appetite suppression and nighttime eating: if nighttime eating was a pattern, appetite suppression changes that pattern. Sleep can worsen if nighttime waking is…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #117 · Sourcing › Logistics · 29 Jun 2026 · 21 likes On post #113 — agreed on the reasoning, with one qualification. Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is evidence of a…
-
Publication patterns in the BPC-157 literature, examined Replied, post #17 · Compounds › Repair & healing peptides · 20 Jun 2026 · 23 likes Publication patterns in the BPC-157 literature: a large proportion of the evidence comes from one research group. That is not necessarily wrong — one group can do…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #46 · Analytics › Home & field testing · 13 Jun 2026 · 22 likes Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide…
-
Second pass at: Programming during a large energy deficit Replied, post #24 · Nutrition & Training › Resistance training · 12 Jun 2026 · 12 likes Frequency: three sessions per week of full-body training is easier to maintain than higher frequencies on an energy deficit. Consistency beats intensity when recovery…
-
Reference intervals: how they are constructed and why one in twenty flags — does this… Replied, post #4 · Clinical › Bloodwork · 11 Jun 2026 · 0 likes Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ from lipids on a fed draw. Always note whether the test was fasting when…
-
Language barriers in accessing a prescription abroad Started this topic · Access › International · 4 Jun 2026 · 49 likes Language barriers in accessing a prescription abroad Writing it up because I had to work it out twice and would rather nobody else did. Documenting an access outcome,…
-
A structured critique template this community uses — a second dataset Replied, post #3 · Evidence › Study critique · 4 Jun 2026 · 3 likes Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and…
-
Why we ask for units every single time, with three examples of what goes wrong — what… Replied, post #19 · Start Here › How to Ask · 27 May 2026 · 18 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #49 · Practice › Interactions · 23 May 2026 · 27 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…
-
GLP-1 receptor distribution: central and peripheral Replied, post #52 · Pharmacology › Receptor biology · 18 May 2026 · 9 likes Central versus peripheral action: GLP-1 agonism works through both central nervous system effects (appetite) and peripheral effects (gastric motility, insulin). The…
-
Official shortage notices and what they authorise Replied, post #40 · Access › Shortages · 8 May 2026 · 9 likes post #39 answers the question as asked. The question underneath it is different. Resuming after a gap: after a gap of days or a few weeks, most people resume at the…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #71 · Data & Tools › Calculators · 8 May 2026 · 31 likes The calculators maintained on this site are open-source and verifiable. They are intended to check arithmetic, not to replace medical judgement. Using them is optional…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #31 · Devices › Syringes & needles · 4 May 2026 · 9 likes Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses. Larger barrels hold larger volumes. Choose based on…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #129 · Analytics › Mass spectrometry · 30 Apr 2026 · 0 likes Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+ charge states. Reading an electrospray spectrum means…
-
Tracking intake honestly when appetite is absent Replied, post #10 · Nutrition & Training › Protein & intake · 28 Apr 2026 · 9 likes I read post #8 twice before replying, because I had assumed the opposite. Timing of protein: spreading protein intake across the day, with some at each meal, is more…
-
Spreadsheets: an appreciation — what changed since Replied, post #14 · Lounge › Off topic · 7 Apr 2026 · 8 likes On post #10 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #33 · Clinical › Comorbidities · 5 Apr 2026 · 0 likes Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral medications and for reconstituted solutions. Discussing specific…
-
The most common factual error about semaglutide on the internet — what changed since Replied, post #42 · Compounds › Semaglutide · 6 Mar 2026 · 6 likes post #41 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
The lowest dose that does anything: is that a real question? Replied, post #29 · Practice › Dosing & titration · 3 Mar 2026 · 0 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #9 · Evidence › Journal club · 2 Mar 2026 · 28 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
Measurement error in a self-reported exposure Replied, post #50 · Evidence › Study critique · 24 Feb 2026 · 0 likes Worth separating two things that post #46 runs together. Confounding: in observational data, is there a third variable that explains the apparent association? In…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #96 · Analytics › Mass spectrometry · 15 Feb 2026 · 6 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass.
-
Follow-up: Search filters: what is missing Replied, post #32 · Meta › Site feedback · 12 Feb 2026 · 5 likes Feature requests: if the site would work better with a feature it does not have (better search, different filtering, new section) suggest it here with the reasoning.
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #128 · Analytics › Home & field testing · 7 Feb 2026 · 4 likes False positives and false negatives: no test has 100% sensitivity and 100% specificity. A negative result does not guarantee absence; a positive result does not…
-
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #27 · Compounds › Semaglutide · 27 Jan 2026 · 0 likes The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people without diabetes. That decoupled the cardiovascular argument…
-
EU-wide position versus national implementation — what changed since Replied, post #13 · Regional › European Union · 13 Jan 2026 · 19 likes Germany: BfArM implements EU framework. Statutory insurance (the majority) excludes "lifestyle medicines" including weight management. Private prescription is common.…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Started this topic · Analytics › Mass spectrometry · 1 Jan 2026 · 2 likes Asking directly, because I could not find a straight answer: Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Posting the method…
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #5 · Regional › UK & Ireland · 21 Dec 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Journal club: how we handle discontinuation in obesity trials — what changed since Replied, post #15 · Evidence › Journal club · 10 Nov 2025 · 31 likes Picking up post #12: that is the part I would want checked first. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy.…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #30 · Compounds › Oral incretins · 4 Nov 2025 · 10 likes post #29 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Sleep tracking data and its considerable limitations Replied, post #56 · Wellbeing › Sleep · 22 Oct 2025 · 2 likes I read post #54 twice before replying, because I had assumed the opposite. Stimulants and sleep: if supplementing with caffeine or other stimulants for energy during…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #40 · Wellbeing › Mental health · 21 Oct 2025 · 0 likes Coming back to post #38, because the follow-up matters more than the original answer. Motivation and expectation: starting with clear motivation and realistic…
-
Availability by country, dated, with primary sources Replied, post #22 · Access › International · 16 Oct 2025 · 21 likes On post #18 — agreed on the reasoning, with one qualification. Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers.…
-
Reading SURMOUNT-1 without the press release Replied, post #34 · Compounds › Tirzepatide · 15 Oct 2025 · 0 likes SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather than a symptom scale. Two parallel trials, with and…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #53 · Analytics › HPLC & UHPLC · 24 Sep 2025 · 0 likes Coming back to post #51, because the follow-up matters more than the original answer. Area percent is not mass percent. It is a proportion of absorbance, weighted by…
-
Airline travel with a temperature-sensitive injectable Replied, post #3 · Devices › Cold chain · 18 Sep 2025 · 22 likes This follows post #2 rather than contradicting it. Temperature logging: devices that record temperature over time let you confirm cold chain was maintained. Useful if a…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #92 · Evidence › Study critique · 15 Sep 2025 · 0 likes Confounding: in observational data, is there a third variable that explains the apparent association? In randomised data, randomisation should balance unknown…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #77 · Evidence › Study critique · 15 Sep 2025 · 10 likes post #76 is right about the mechanism and I think understates the practical bit. What makes a methodological criticism substantive: it identifies a specific feature of…
-
Confounding by indication, explained with a concrete example Replied, post #25 · Evidence › Study critique · 3 Sep 2025 · 0 likes Bias towards the null and bias away from the null: different criticisms have different directions. Differential dropout might bias away from null; conservative…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #98 · Access › Insurance & coverage · 29 Aug 2025 · 0 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #73 · Access › Insurance & coverage · 9 Aug 2025 · 0 likes I read post #71 twice before replying, because I had assumed the opposite. Denial letters: the stated reason tells you exactly what to submit next. A denial is not…
-
A ten-fold dose error caught before injection — one year on Replied, post #104 · Devices › Syringes & needles · 4 Aug 2025 · 8 likes post #103 is right about the mechanism and I think understates the practical bit. Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #84 · Clinical › Comorbidities · 2 Aug 2025 · 17 likes I read post #82 twice before replying, because I had assumed the opposite. Type 2 diabetes: the population with the largest evidence base for these compounds. The…
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #5 · Compounds › Retatrutide · 7 Jul 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #17 · Analytics › COA interpretation · 27 Jun 2025 · 11 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Reporting a disappointing outcome, and why it belongs here Replied, post #18 · Outcomes › Progress reports · 25 Jun 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Coming back to: When "no data" is the complete and final answer Replied, post #19 · Compounds › Other compounds · 20 Jun 2025 · 27 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #12 · Evidence › Journal club · 5 Jun 2025 · 3 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #16 · Compounds › Semaglutide · 4 Jun 2025 · 0 likes Worth separating two things that post #12 runs together. The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4…
-
Coming back to: Getting a referral rather than a refusal Replied, post #18 · Clinical › Prescriber conversations · 31 May 2025 · 19 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #51 · Compounds › Repair & healing peptides · 29 May 2025 · 12 likes TB-500 is usually the 7-residue actin-binding fragment of thymosin beta-4, not the full 43-residue protein. The two are routinely conflated in supplier documentation…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Started this topic · Compounds › Tirzepatide · 27 May 2025 · 4 likes Asking directly, because I could not find a straight answer: What the GIP component of tirzepatide is thought to contribute, and how confident we can be — the long…
-
Why the timeline is on the right and not the left Replied, post #20 · Meta › Site feedback · 21 May 2025 · 1 like Performance: if pages are slow to load, timeouts occur, or the site is unresponsive, that is worth reporting with details (when, which pages, how slow).
-
Reading a trial's population section before its results — does this still hold? Replied, post #120 · Evidence › Trials · 19 May 2025 · 25 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #23 · Devices › Cold chain · 2 May 2025 · 1 like Coming back to post #21, because the follow-up matters more than the original answer. Reconstituted solutions: once reconstituted, solutions are less stable than…
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #63 · Evidence › Journal club · 26 Mar 2025 · 9 likes On post #59 — agreed on the reasoning, with one qualification. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease.…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #120 · Compounds › Other compounds · 20 Mar 2025 · 0 likes post #119 answers the question as asked. The question underneath it is different. Naming conventions for research peptides cause confusion because suppliers do not…
-
Introducing myself and asking whether my planned first topic belongs anywhere Replied, post #17 · Start Here › Welcome · 15 Mar 2025 · 8 likes Picking up post #14: that is the part I would want checked first. Your introduction is well framed. You have given enough context that people can actually answer. That…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #98 · Pharmacology › Receptor biology · 14 Mar 2025 · 1 like post #97 answers the question as asked. The question underneath it is different. Amylin receptor signalling: amylin promotes satiety and slows gastric emptying through…
-
What we do not know about retatrutide, listed explicitly Replied, post #102 · Compounds › Retatrutide · 19 Feb 2025 · 0 likes Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood glucose. The paradox resolves because glucagon agonism also…
-
Transit times by route, from a logged dataset — the long version Replied, post #61 · Sourcing › Logistics · 17 Feb 2025 · 0 likes Picking up post #58: that is the part I would want checked first. Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is evidence of a…
-
Adjudicated events and why the definition matters — the long version Replied, post #14 · Evidence › Trials · 17 Feb 2025 · 13 likes I read post #12 twice before replying, because I had assumed the opposite. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the…
-
Second pass at: Regression to the mean in progress reports Replied, post #54 · Research Methods › Statistics · 13 Feb 2025 · 14 likes Effect sizes: the magnitude of a difference, not just whether it is statistically significant. A difference that is significant (p
-
Protein density versus volume when you cannot eat much Replied, post #66 · Nutrition & Training › Protein & intake · 4 Feb 2025 · 13 likes Worth separating two things that post #62 runs together. Timing of protein: spreading protein intake across the day, with some at each meal, is more practical than…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #52 · Evidence › Journal club · 30 Jan 2025 · 1 like On post #48 — agreed on the reasoning, with one qualification. Session format: read the paper before posting. The discussion is much better when everyone has. Start…
-
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #25 · Documentation › Doc review · 15 Jan 2025 · 0 likes Citation checking: if a maintained page cites a paper, the citation should match what the paper actually says. If you notice a mismatch, post it here.
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #9 · Analytics › COA interpretation · 15 Jan 2025 · 11 likes Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #123 · Compounds › Tirzepatide · 1 Jan 2025 · 17 likes post #122 is right about the mechanism and I think understates the practical bit. Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide,…
-
When "no data" is the complete and final answer Replied, post #50 · Compounds › Other compounds · 25 Dec 2024 · 22 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or…
-
People with a low starting BMI: where the evidence stops Replied, post #22 · Clinical › Special populations · 9 Dec 2024 · 0 likes Adolescents: a distinct evidence base exists. The compounds are not approved for routine adolescent obesity but are being studied. Adolescent physiology and psychology…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #14 · Practice › Side effects · 20 Nov 2024 · 2 likes I read post #12 twice before replying, because I had assumed the opposite. Nausea: the most common side effect and the most dose- and titration-dependent one. It is…
-
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #28 · Sourcing › Independent verification · 11 Nov 2024 · 0 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
-
Time to steady state after a dose increase Replied, post #113 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 21 likes Picking up post #110: that is the part I would want checked first. Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability.…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #61 · Access › Shortages · 11 Oct 2024 · 12 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #47 · Analytics › COA interpretation · 6 Sep 2024 · 6 likes On post #43 — agreed on the reasoning, with one qualification. A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot…
-
Coming back to: Pricing far outside the range, in either direction Replied, post #18 · Sourcing › Red flags · 30 Jul 2024 · 27 likes Rapid supplier turnover: a supplier that changes corporate structure, domain name, or contact repeatedly in short time windows raises suspicion about stability and…
-
Guidelines revision: what changed and why Replied, post #133 · Meta › Announcements · 29 Jul 2024 · 0 likes Staff announcements, policy changes, and scheduled maintenance. Read-only except for questions clarifying what was announced.
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #8 · Practice › Dosing & titration · 6 Jul 2024 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Two sessions a week versus four: what the evidence supports — a second dataset Replied, post #9 · Nutrition & Training › Resistance training · 12 Jun 2024 · 0 likes Maintenance is the goal: preserving lean mass and strength during weight loss is the goal of resistance training in this context, not building new muscle. That goal is…